US FDA re-tackles device changes needing a new 510(k)
This article was originally published in Clinica
The controversial issue of what types of changes made to medical devices already on the US market would warrant a new pre-market notification or 510(k) application is to be discussed at a public meeting organized by the US Food and Drug Administration on 13 June.
You may also be interested in...
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Sixty-nine guidance documents have been posted on the tracker since its last update.
A UK regulator with the MHRA is concerned that bioanalytical laboratories are not being given enough time to do their job properly by drug companies under pressure to ensure their clinical trials remain on schedule.
The UK regulator is expecting a rise in amendments and deviations to ongoing clinical investigations of medical devices due to the COVID-19 pandemic and has issued advice on how companies should manage these.